Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2025-12-24 @ 2:45 PM
NCT ID:
NCT02555059
Eligibility Criteria:
Inclusion Criteria:
* Female and male pediatric patients (less than 15 years old) with a diagnosis of complicated cystitis, pyelonephritis, cystic fibrosis, or anthrax infected by ciprofloxacin-active microorganisms, i.e. Bacillus anthracis, Escherichia coli, Pseudomonas aeruginosa.
* Patients for whom the decision to initiate treatment with Ciproxan injection was made as per investigator's routine treatment practice.
Exclusion Criteria:
* N/A
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
14 Years
Study:
NCT02555059
Study Brief:
Protocol Section:
NCT02555059